Desmin degradation in the skeletal muscle of patients with chronic critical illness
-
Published:2024-08-02
Issue:2
Volume:110
Page:283-296
-
ISSN:2658-655X
-
Container-title:Российский физиологический журнал им И М Сеченова
-
language:
-
Short-container-title:Rossijskij fiziologičeskij žurnal im. I.M. Sečenova
Author:
Zaripova К. А.1, Tyganov S. А.1, Turtikova О. V.1, Skiteva Е. N.12, Zabrodskaya Y. М.234, Kondratiev S. А.5, Kondratieva Е. А.24, Kondratiev А. N.2, Shenkman B. S.1
Affiliation:
1. Institute of Biomedical Problems, Russian Academy of Sciences 2. Russian National Institute of Chemistry 3. North-Western State Medical University named after I.I. Mechnikov 4. S.M. Kirov Military Medical Academy 5. AIMIS Healthcare Group, Сlinic Athonitissa
Abstract
Critical illness myopathy (CIM) is a primary myopathy that develops in critically ill patients. Histologic features of CIM include a general decrease in muscle fiber cross-sectional area and a predominant loss of the motor protein myosin. These features are observed in the absence of inflammatory infiltrates but with detectable cytokine activation. The purpose of this study was to examine the state of the extracellular matrix of the human soleus muscle under conditions of CIM caused by chronic impairment of consciousness. Incisional muscle biopsies were taken from the soleus muscle of 6 patients who were in a chronic critical condition and were treated in the Department of Anesthesiology and Reanimation at the A.L. Polenov Russian Research Institute - branch of the Almazov National Medical Research Center. The study included patients with a chronic impairment of consciousness lasting at least 2 months. Muscle biopsies taken from healthy men were used as controls. The biopsies were obtained using needle biopsy under local anesthesia. Using histological staining of tissue sections, it was determined that patients with CIM exhibited a significant increase in collagen area, surpassing the control value by 82%. An increased mRNA content of collagens I, III, and VIa was also observed, along with an increase in the protein content of collagen I and III. At the same time, we did not observe any changes in the content of fibronectin and extracellular tissue growth factor mRNA. However, we did observe an increase in the mRNA of the integrin A7 subunit. The results obtained indicate significant skeletal muscle fibrosis under CIM conditions. Further studies on the signaling pathways that regulate this process are needed.
Publisher
The Russian Academy of Sciences
Reference63 articles.
1. Пирадов МА, Супонева НА, Вознюк ИА, Кондратьев АН, Щеголев АВ, Белкин АА, Зай- цев ОС, Пряников ИВ, Петрова МВ, Иванова НЕ, Гнедовская ЕВ, Рябинкина ЮВ, Серге- ев ДВ, Язева ЕГ, Легостаева ЛА, Фуфаева ЕВ, Петриков СС (2020) Хронические нарушения сознания: терминология и диагностические критерии. Результаты первого заседания Российской рабочей группы по проблемам хронических нарушений сознания. Анналы неврол 14(1): 5–16. [Piradov MA, Suponeva NA, Voznyuk IA, Kondratyev AN, Shchegolev AV, Belkin AA, Zaitsev OS, Pryanikov IV, Petrova MV, Ivanova NE, Gnedovskaya EV, Ryabinkina YuV, Sergeev DV, Iazeva EG, Legostaeva LA, Fufaeva EV, Petrikov SS (2020) Chronic disorders of consciousness: terminology and diagnostic criteria. The results of the first meeting of the Russian Working Group for Chronic Disorders of Consciousness. Annu Clin Exp Neurol 14(1): 5–16. (In Russ). https://doi.org/10.25692/ACEN.2020.1.1 2. Larsson L, Friedrich O (2016) Critical Illness Myopathy (CIM) and Ventilator-Induced Diaphragm Muscle Dysfunction (VIDD): Acquired Myopathies Affecting Contractile Proteins. Compr Physiol 7(1): 105–112. https://doi.org/10.1002/cphy.c150054 3. Friedrich O, Diermeier S, Larsson L (2018) Weak by the machines: muscle motor protein dysfunction – a side effect of intensive care unit treatment. Acta Physiol (Oxf) 222(1). https://doi.org/10.1111/apha.12885 4. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, Argentini C, Schiaffino S (2000) Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 28(1): 34–45. https://doi.org/10.1097/00003246-200001000-00006 5. Derde S, Hermans G, Derese I, Guiza F, Hedstrom Y, Wouters PJ, Bruyninckx F, D’Hoore A, Larsson L, Van den Berghe G, Vanhorebeek I (2012) Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med 40(1): 79–89. https://doi.org/10.1097/CCM.0b013e31822d7c18
|
|